Journal
FOLIA HISTOCHEMICA ET CYTOBIOLOGICA
Volume 48, Issue 1, Pages 7-11Publisher
VIA MEDICA
DOI: 10.2478/v10042-010-0014-2
Keywords
lung cancer; immunohistochemistry; clinical trials; protein expression
Categories
Ask authors/readers for more resources
Quantitative immunohistochemistry remains an important tool in translational lung cancer research with hopes to improve patient outcomes and avoid unnecessary therapies. Present review is aimed to summarize the use of immunohistochemical markers for improved prognostic information and prediction of treatment benefit. Several of these markers are currently explored in phase II - III clinical studies to individualize the treatment of lung cancer.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available